Konstantinos Marmagkiolis
Overview
Explore the profile of Konstantinos Marmagkiolis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
125
Citations
685
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Desai S, Aziz M, Marmagkiolis K, Cilingiroglu M, Iliescu C, Ynalvez L
Curr Cardiol Rep
. 2025 Mar;
27(1):65.
PMID: 40035980
Purpose Of Review: This review examines the current evidence and management strategies for stable coronary artery disease (CAD) and acute coronary syndrome (ACS) in patients with cancer. We outline the...
2.
Marmagkiolis K, Caballero J, Votsis S, Ninios V, Cilingiroglu M, Boudoulas K, et al.
Catheter Cardiovasc Interv
. 2025 Feb;
PMID: 39910697
In 2023-2024, there was a surge in research on structural heart disease. This review aims to provide a comprehensive overview of the field for both general and interventional cardiologists, especially...
3.
Marmagkiolis K, Caballero J, Iliescu C
JAMA Cardiol
. 2025 Jan;
10(3):297.
PMID: 39841435
No abstract available.
4.
Mutlu D, Akman Z, Belpinar M, Iliescu C, Marmagkiolis K, Cilingiroglu M
J Invasive Cardiol
. 2025 Jan;
PMID: 39745724
No abstract available.
5.
Mutlu D, Inanc I, Zanbak Mutlu O, Marmagkiolis K, Iliescu C, Cilingiroglu M
US Cardiol
. 2024 Nov;
18:e20.
PMID: 39588174
The absence of a Food and Drug Administration-approved percutaneous valve technology for the treatment of severe aortic regurgitation (AR) presents a challenge for high-risk patients. In this report, we describe...
6.
Boudoulas K, Pitsis A, Iliescu C, Marmagkiolis K, Triposkiadis F, Boudoulas H
Cardiology
. 2024 Sep;
:1-11.
PMID: 39226885
Background: Floppy mitral valve/mitral valve prolapse (FMV/MVP) is a complex entity in which several clinical manifestations are not directly related to the severity of mitral regurgitation (MR). Summary: Patients with...
7.
Marmagkiolis K, Monlezun D, Caballero J, Cilingiroglu M, Brown M, Ninios V, et al.
Int J Cardiol
. 2024 Apr;
408:132091.
PMID: 38663811
Introduction: We conducted the first comprehensive evaluation of the therapeutic value and safety profile of transcatheter mitral edge-to-edge repair (TEER) and transcatheter mitral valve replacement (TMVR) in individuals concurrently afflicted...
8.
Ali A, Jewani P, Bourdillon M, Koutroumpakis E, Khalaf S, Charitakis K, et al.
Front Cardiovasc Med
. 2024 Mar;
11:1337957.
PMID: 38486704
Cangrelor, a potent intravenous P2Y12 platelet inhibitor, has demonstrated effectiveness in reducing ischemic events without a corresponding increase in severe bleeding during percutaneous coronary intervention, as evidenced by the CHAMPION-PHOENIX...
9.
Boudoulas K, Marmagkiolis K, Iliescu C, Boudoulas H
Cardiovasc Revasc Med
. 2024 Jan;
62:18-20.
PMID: 38195344
No abstract available.
10.
Boudoulas K, Triposkiadis F, Koenig S, Marmagkiolis K, Iliescu C, Pitsis A, et al.
Heart Fail Rev
. 2023 Jul;
28(5):1201-1209.
PMID: 37414917
Acute severe mitral regurgitation (MR) is rare, but often leads to cardiogenic shock, pulmonary edema, or both. Most common causes of acute severe MR are chordae tendineae (CT) rupture, papillary...